Exelon

David Garbe, The Beacon News Aurora ; Feb 21, 2006 State Rep. Linda Chapa LaVia said Monday she is co-sponsoring a bill that would extend the current freeze on electricity prices through 2010. Backed by Gov. Rod Blagojevich and a variety of consumer advocates, the bill is the latest of several attempts to halt the state' progress toward a free market electricity system that is s supposed to begin next year. Under a deregulation plan devised a decade ago and approved by the Illinois Commerce Commission last month, utilities like ComEd will begin buying power on an open market in 2007. No one denies that will mean higher costs for consumers, although estimates for how big the increase will be range from less than 15 percent to nearly 40 percent. Although that might be painful in the short term, deregulation advocates say market competition is the only long-term way to achieve realistic prices for consumers and profit incentives to push power companies toward efficiency. Democrats and the Citizens Utility Board watchdog group disagree, pointing out that the current system seems to work fine. Illinois residents today enjoy low-to-average rates compared with other states, and ComEd' s parent company Exelpn has enjoyed an average profit margin of nearly 10 percent for the last five years. That' about normal for most regulated utilities, although the CUB has attacked Exekon for making s unfairly large profits off Illinois nuclear plants' ability to generate some of the cheapest power in the world -- thanks to the federal government' help in disposing the radioactive waste and s Illinois consumers' help in paying for plant construction through historically high electric rates. Given all that, the political decision seems easy. "Now is not the time for an electric rate increase, " Chapa LaVia said. "I will not stand idly by and let my constituents and small business owners have their pockets picked by companies that are already making massive profits." House Bill 1944, which Chapa LaVia is co-sponsoring with a representative from Kankakee, seeks to freeze Illinois power rates at their current levels until 2010, hoping the electricity market will have produced more competition -- and thus lower prices -- by then. ComEd officials said the effort is coming much too late in the game: the electric industry has already restructured to fit deregulation plans and cannot be brought back with simple legislative fiat. The direction that we want to go. This solution is something that we can really use in terms of implementation." That's also the case in the area of positioning; there is a strong need to conduct workshops and meetings with our internal line partners to make sure that the right message or right research stimuli is being developed. Can you talk more about the role of a consultative approach in your training and guiding of researchers at Novartis? I think, first and foremost, our researchers need to have the basic, fundamental knowledge, the technical competencies in market research. But just as important, maybe even more so, are consulting skills. When people start out in market research myself included we have more of a project management mentality. We identify the objectives, design the study; the result comes back, and we present the information. But as people progress in their careers, there's a need to become more consultative. To be an effective consultant, you have to understand the fundamentals; the technical competency has to be there. Second, you have to understand the business. And third, you have to be able to think like our internal customers, our line partners. You have to know what's important to them and what kind of information they need to help them drive their decisions. A lot of times when we conduct research, there may be a lot of information that's not really given to us by our internal.
The most common behavioral problems in AS children are hyperactivity, attention deficit and difficulties initiating and maintaining sleep. Sleep problemsare usuallydetectable at severalmonthsof age and persist for many years. Long latencies to sleep and prolonged awakenings at night lead to fatigue and sleepinessupon morning awakeningand cause a chronic sleep debt which may potentiate other behavioraland neurologicproblems. Observations in work with human babies reveal a correlation between the timing of the consolidation of nocturnal sleep and the normal onset of rhythmic melatonin secretion, both of which occur when the infant is about 3 months 0Ids.6.Likewise, the concurrent decline in melatonin secretion and sleep efficiencywith age are thoughi to be related phenomena; for example, middle-aged and elderly insomniacs reportedly exhibit lower melatonin production than do good sleepers of the same age7.8.Initial studies regarding the' acute effects of melatonin in humans revealed that pharmacological doses of the hormone induce sleepinessand sleep911.Recently it has been shown that low melatonin.

Arkema Inc. Biokinetics, Inc. Boehringer Laboratories, Inc. Croda Inc. Custom Processing Services, Inc. DuPont 3xelon FirstEnergy Corp. Gartner Jacobs Engineering Joule Scientific Staffing Solutions Oak Ridge Institute for Science and Education ORISE ; Maryland Pepsi Bottling Group PSEG Public Service Enterprise Group ; Q Pharma South Jersey Industries SPS Technologies URS Washington Division. Rofl this is normal too and the tachycardia, fast heart beat will go back to normal and kytril. ICH guidance for industry. Q3C impurities: residual solvents. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research CDER ; , Center for Biologics Evaluation and Research CBER ; , 1997. Guidance of Industry. Stability testing of drug substances and drug products., U.S. Department of Health and Human Services, Food and Drug.
James D. Colson, MD Clinical Assistant Professor of Anesthesiology Attending Staff, Center for Interventional Pain Medicine University of Michigan 1H247 UH, 1500 E. Medical Center Drive Ann Arbor, MI 48130 E-mail: colsonj umich and leukeran!

Therefore, some doctor’ s offices and clinics may use the fda approved method, while others may use an alternative method, though they should all have similar success rates and mysoline.

Diabetes monitor - frequently asked questions a number of studies have shown that regular physical activity can significantly reduce the risk of developing type 2 diabetes. Defined as: Tetraiodothyronine T4 ; : 20 bolus followed by 10 g infusion or 50100 g IV bolus followed by 2550 g IV every 12h ; Vasopressin: 0.00030.0007 U kg minute 0.3-0.7 mU kg per minute ; to a maximum dose of 2.4 U h Methylprednisolone: 15 mg kg 1 g ; IV every 24 h Indications: 2-dimensional echocardiographic assessment of ejection fraction 40% or Hemodynamic instability includes shock, unresponsive to restoration of normovolemia and requiring vasoactive support [dopamine 10 g minute or any vasopressor agent] ; Consideration should be given to its use in all donors Optimum hemoglobin: 90100 g L; for unstable donors, lowest acceptable level is 70 g For platelets, INR, PTT, there are no predefined targets; transfuse in cases of clinically relevant bleeding No other specific transfusion requirements. Daily blood cultures Daily urine culture Daily endotracheal tube cultures Administer antibiotics for presumed or proven infection. 12-lead electrocardiogram Troponin I or T, every 12 h 2-dimensional echocardiography - Should be performed only after fluid and hemodynamic resuscitation - If ejection fraction 40% then repeat echocardiography at 612 h intervals Chest radiography every 24 h and as needed Bronchoscopy and bronchial wash gram stain and culture Routine endotracheal tube suctioning, rotation to lateral position every 2 h Mechanical ventilation targets: - Tidal volume: 810 ml kg, PEEP: 5 cm H20, PIP: 30 cm H2O - pH: 7.357.45, PaCO2: 3545 mm Hg, PaO2: 80 mm Hg, O2 saturation: 95% Recruitment maneuvers for oxygenation impairment may include: - Periodic increases in PEEP up to 15 H2O - Sustained inflations PIP at 30 cm H2O times 3060 s ; - Diuresis to normovolemia and atrovent.

Discount Drugs Select from list aciphex actos adalat albenza aldactone allegra altace amaryl amoxil ampicillin arava arcoxia atacand atarax atropisol atrovent avandia avapro aygestin bactrim benzac biaxin breast success buy acomplia online buy cialis online buy cialis soft tabs online buy clomid online buy levitra online buy propecia online buy soma online buy ultram online buy viagra online buy viagra soft tabs online capoten carafate cardizem cardura casodex caverta ceclor celebrex celexa chloromycetin cipro clarinex claritin cleocin colospa cordarone coreg coumadin cozaar crestor danocrine deltasone depakote desyrel diamox diflucan diltiazem diltiazem hci diovan ditropan doxycycline duphaston duricef ed trial pack effexor xr elavil enhance9 euphoria cologne euphoria perfume evista exelon feldene female rx oil female rx plus flagyl flomax florinef floxin fosamax geodon gestanin glucophage glucotrol xl hoodia gordonii hoodia patch human growth agent hydrea hytrin ilosone imdur imodium imuran inderal inderal la indocin isoptin isordil joint formula kamagra kamagra oral jelly keflex lamisil oral lasix levaquin lexapro lioresal lipitor liquid rx plus lopressor lotensin lozol luvox maxolon mevacor mexitil microzide minipress minocin motilium motrin multi vitamin naprosyn neurontin nexium nimotop nizoral nolvadex norplant norvasc ortho tri-cyclen pamelor parlodel paxil pepcid periactin persantine phenergan plavix plendil ponstel prandin pravachol premarin premium diet patch prevacid prilosec protonix provera proviron prozac pulmicort rebetol reglan retrovir rheumatrex risperdal rulide serevent silagra sinequan singulair sumycin super greens suprax symmetrel synthroid tadalis sx tamiflu tegretol tenormin tofranil topamax trecator-sc vasotec verapamil viramune virility patch rx virility pills voltaren voltarol vprx oil yerba diet zanaflex zantac zebeta zerit zero nicotine patch zestril zithromax zocor zofran zoloft zovirax zyban zyprexa zyrtec empty buy acomplia online buy cialis online buy cialis soft online buy clomid online buy levitra online buy propecia online buy soma online buy ultram online buy viagra online buy viagra soft online buy propecia cialis viagra sale viagra live help desk shipping time and cost where do the pills come from. Epsteins request for a copy of the answers exelon provided to the nrc onmay 24, 2005 and combivent. Where to buy Exelon Moore, RW; Peterson, RE. 1988 ; Androgen catabolism and excretion in 2, 3, 7, rats. Biochem Pharmacol 37: 560-562. Moore, RW; Potter, CL; Theobald, HM; et al. 1985 ; Androgenic deficiency in male rats treated with 2, 3, 7, Toxicol Appl Pharmacol 79: 99-111. Moore, RW; Parsons, JA; Bookstaff, RC; et al. 1989 ; Plasma concentrations of pituitary hormones in 2, 3, 7, male rats. J Biochem Toxicol 4: 165-172. Moore, RW; Jefcoate, CR; Peterson, RE. 1991 ; 2, 3, 7, inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicol Appl Pharmacol 109: 85-97. Moore, RW; Mably, TA; Bjerke, DL; et al. 1992 ; In utero and lactational 2, 3, 7, TCDD ; exposure decreases androgenic responsiveness of male sex organs and permanently inhibits spermatogenesis and demasculinizes sexual behavior in rats. Toxicologist 12: 81. Morrissey, RE; Schwetz, BA. 1989 ; Reproductive and developmental toxicity in animals. In: Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products. 2nd ed. Kimbrough, RD; Jensen, AA; eds. Amsterdam: Elsevier; pp. 195-225. Morrissey, RE; Harris, HW; Diliberto, JJ; 1992 ; Limited PCB antagonism of TCDD-induced malformations in mice. Toxicol Lett 60: 19-25. Morse, DC; Groen, D; Veerman, M; et al. 1993 ; Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol 122 1 ; : 27-33. Morse, DC; Wehler, EK; Wesseling, W; et al. 1996 ; Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls Aroclor 1254 ; . Toxicol Appl Pharmacol 136 2 ; : 269-279. Murray, FJ; Smith, FA; Nitschke, KD; et al. 1979 ; Three-generation reproduction study of rats given 2, 3, 7, TCDD ; in the diet. Toxicol Appl Pharmacol 50: 241-252. Nadler, RD. 1969 ; Differentiation of the capacity for male sexual behavior in the rat. Horm Behav 1: 53-63. Nagarkatti, PS; Sweeney, GD; Gauldie, J; et al. 1984 ; Sensitivity of suppression of cytotoxic T cell generation by 2, 3, 7, TCDD ; is dependent on the Ah genotype of the murine host. Toxicol Appl Pharmacol 72: 169-176. Nebert, DW; Gielen, JE. 1972 ; Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. Fed Proc 31: 1315-1325. Ness, DK; Schantz, SL; Moshtaghian, J; et al. 1993 ; Effects of perinatal exposure to specific PCB congeners on thyroid hormone concentrations and thyroid histology in the rat. Toxicol Lett 68 3 ; : 311-323. Neubert, D; Dillman, I. 1972 ; Embryotoxic effects in mice treated with 2, 4, 5-trichlorophenoxy acetic acid and 2, 3, 7, NS Arch Pharmacol 272: 243-264. Neumann, F; von Berswordt-Wallrabe, R; Elger, W; et al. 1970 ; Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horm Res 26: 337-410. Nikolaidis, E; Brunstrom, B; Dencker, L. 1988a ; Effects of the TCDD congeners 3, 3N, 4, and 3, 3N, 4, on lymphoid development in the bursa of Fabricius of the chick embryo. Toxicol Appl Pharmacol 92: 315-323.

Exelon children Tell us what you think sponsored links eye drops get the answers you' re looking for and synthroid and Exelon online. Despite the events of September 11 and seemingly oblivious to the fact that terrorists are targeting nuclear power plants, the nuclear industry and its proponents in government are plotting a nuclear renaissance. The U.S. Department of Energy DOE ; has put forth a plan that they claim would result in new nuclear reactors by 2010. The Nuclear Energy Institute NEI ; , the industry's propagandists and lobbyists, have their own plan to construct fifty nuclear reactors by 2020. As part of the DOE's Nuclear Power 2010 initiative, the Bush administration proposes to spend a total of .5 million in 2003 to demonstrate the early site permit ESP ; process and to conduct additional nuclear power plant research. The Department of Energy will subsidize these limited liability nuclear corporations' attempts to site new nuclear reactors by splitting the cost of the NRC's siting process. Three nuclear corporations: Exelon, Entergy and Dominion Energy have indicated that they will apply for early site permits at three existing nuclear plant sites. Dominion Energy will seek an early site permit for the North Anna site in Virginia; Entergy at the Grand Gulf site in Mississippi, and Exelon will seek an early site permit for the Clinton site in Illinois. These nuclear corporations plan to submit their applications in the fall 2003, and expect that the Nuclear Regulatory Commission NRC ; to approve the permits by 2005. However, not one of these nuclear corporations has designated a specific reactor design that it intends to build. This reticence on the part of Exelon, Entergy and Dominion is not due to the lack of potential nuclear plant designs. The NRC has already certified several nuclear power plant designs including: General Electric's Advanced Boiling Water Reactor, Combustion Engineering's System 80-plus, and the Westinghouse AP600. Rather, these nuclear corporations have failed to choose a specific nuclear reactor design because none of the reactors are economically viable. Even nuclear industry proponents at the American Physical Society acknowledge that despite the fact that "the cost of electricity for these plants advanced light water reactors ; has been improved and is estimated to be lower than today's nuclear plants by about 20% .the capital cost is still too high to be competitive with gas-fired plants in the U.S. rate de-regulated market, assuming present gas prices and no environmental credits, requiring continued efforts to bring down the capital costs." The nuclear corporations and the NEI are currently pressuring the Nuclear Regulatory Commission to change its regulations for early site permits to accommodate the nuclear industry's indecisiveness. Term weight-loss in non-obese patients, but found to cause heart-valve disease in women.176 It seems reasonable to attribute the harm in these cases to the fact that Misoprostol, Thalidomide, and Fen-Phen had not undergone clinical studies for the non-indicated uses to which they were put. Reports in peer-reviewed journals of physician accounts of unapproved indications, after all, is no substitute for controlled clinical trials and careful FDA evaluation of safety profiles.177 Critics argue that off-label use in these cases turned patients into unwitting guinea pigs, subjected to human experimentation in which no records were kept of harms and benefits. The unethical experimentation objection to off-label use is unpersuasive, however, because it fails to adequately distinguish between medical research and medical practice.178 Whereas practice is meant to provide diagnosis, prevention, or treatment to the individual patient, research aims to develop or contribute to scientific knowledge of the physiological processes involved in human functioning.179 Since off-label activity is intended to benefit the individual patient and not to further a generalizable understanding of how the human body works, offlabel use, in fact, constitutes standard medical practice and not human experimentation lacking proper scientific controls or patient consent.180 Although the "unethical research" objection to off-label practices is misplaced, there remains a powerful reason to resist non-approved use of medical products with enhancement capabilities. Namely, the profit motive attending the development, manufacture, and prescription of biomedical enhancements threatens to undermine healthcare providers' commitment to consumer-patient health. Because pharmaceuticals bankroll a considerable quantity of scientific research in hopes of commercial success, experimenters have a professional stake in producing favorable data for their product's sponsor, 181 yet rarely make known their financial connection to that spon and detrol.

Clear corneal incision CCI ; is the way to go. In a patient with significant ocular co -morbidity e.g. small pupil, unhealthy cornea etc ; I may opt for a scleral tunnel ST ; . ST may also be considered in your early days of phaco because should you need to convert, the eventual outcome is likely to be more acceptable.
Throughout this issue, my colleagues have discussed several aspects of migraine. In my experience with headache, I find migraines fascinating because of the mystery involved. How do different migraine attacks happen? As a clinician, I know the mechanisms are not well illustrated. Why is migraine one-sided in 70% of sufferers? Why do 20% have aura? We know that there is some sensitivity to chocolate, red wine, and other things, but we don't have the whole picture as yet. We might even believe that the headache classification is well defined, but every time I teach a group of young doctors or medical students, one will come up afterwards and say, "I think I suffer from migraine based on your descriptions. I used to think migraine only described a severe, devastating, nauseating, disabling syndrome. I don't get those, but I do meet the criteria for migraine that you described.'' That many people with migraine are never diagnosed is no surprise. People who have one attack per month know that the headache will bother them, but in a little while it will go away. They don't think "migraine" -- to them it is just a bad headache, so they self-treat with huge doses of NSAIDs nonsteroidal anti-inflammatory drugs ; . On the other end of the spectrum there are "migraineurs" who end up with chronic daily migraines CDM ; , which are severe and require prescription treatment and injections. Then there are plenty of people in the middle. State the policy on procedure compliance and use of controlled documents All work in the plant must be performed in accordance with an approved work document. Approved documents include procedures, maintenance work packages, plant modifications, and radiation work permits, among others. If work cannot be performed in accordance with the approved document: Stop the work. Place the job in a safe condition. Contact your supervisor Resolve the problem. Individuals are responsible for verifying the latest approved revision of a document is being used to perform the work by reviewing the document prior to performing the task and verifying all necessary tools and parts are available. REFER TO THE ROG SPECIFIC STUDY GUIDE s ; FOR SITE SPECIFIC INFORMATION State responsibilities for station cleanliness and housekeeping Each individual is expected to keep his her own workspace as neat as possible and to clean up after completing a job in the station. Leave a work area cleaner than when it was found. Discuss Self-Check It is an Exelon company policy that all work to be performed should include the "Self Checking" process. Self checking is a mental process that is used anytime a task is about to be performed that could have adverse consequences if done incorrectly. Examples of where self-checking should be used are in manipulating a valve or component, connecting test equipment, opening panel doors and entering RCAs RPAs. The steps involved with self-checking are: Stop - Plan and prepare. Stop. Once-daily combination of FTC 200 mg per day ; + ddI 60 kg: 250 mg per day 60 kg: 400 mg per day ; + EFV 600 mg per day ; : 5 pills taken all together, at bedtime, at least two hours after dinner. During study, the new formulation of EFV became available and patients received one 600 mg capsule of EFV, making the once-daily regimen only 3 pills day.
BRACEVILLE, Illinois -- The state of Illinois, with the most reported incidents of radioactive tritium leaks from nuclear power reactors, is suing Commonwealth Edison and its parent company Exelon Corp. for contaminating groundwater and failing to report it. The lawsuit seeks .5 million and free drinking water for Braidwood and Godley, Illinois residents. Plaintiffs want to see records of past and present leaks, and they want to end all use of the "blowdown" pipe from which the radioactive waste has been leaking. At least 12 local families have filed separate lawsuits claiming decreased property values and potential health affects resulting from ingesting tritium. Leaks at the Braidwood reactors occurred on at least nine occasions along a 4.5milelong pipe that normally dumps the tritium into the Kankakee River. Studies have shown that long-term exposure to tritium, through drinking or bathing, can lead to cancer and birth defects. Exelon has said it expects to pay million in fines levied by the state Environmental Protection Agency, and to inspect pipes, pumps, valves, tanks and other equipment that moves tritium-contaminated water at its 10 reactors. On March 13, still more tritium was released from Braidwood when a storm caused the collapse of part of a holding tank's berm. The Nuclear Regulatory Commission has created a task force to investigate potential tritium leaks at all 103 U.S. reactors. Besides Braidwood, tritium leaks are known to be ongoing at Dresden near Morris and the Byron site, all in Illinois; New York's Indian Point and Palo Verde in Arizona. In the face of tests showing elevated levels of tritium in area groundwater near Exelon's reactors, the nuclear industry and the NRC call the pollution harmless. NRC Executive Director for Operations Luis Reyes said guardedly, "The available information on these releases shows no hazard to the public." However, NRC chairman Nils Diaz expressed "concern" because the leaks were uncontrolled. And the information available to Reyes does not include the NRC's task force report which is not due until August and buy kytril.
0 percentage point on the 1-year exelon bonds and 2. Findings The inspector could not complete the determination of the accuracy of the high pressure coolant injection HPCI ; unavailability performance indicator because of Exelon's ongoing evaluation to address a degraded condition discussed in NRC Inspection Report 50-353 01-07 URI 50-353 01-07-02 ; . Exelon is evaluating whether a reduced flow capability in the HPCI system was still adequate for loss of coolant accident conditions. If Exelon's analysis determines that the reduced flow capability was not sufficient, then additional HPCI unavailability will be applied to the calculations of this performance indicator and will likely result in the performance indicator changing color. This item is considered an unresolved item pending completion of Exelon's analysis and review by the inspector. URI ; 50-353 01-12-01.
Thorough blood workups should have been done regularly, at least every few months, and a control group on non-softwood bedding would need to be used to compare results.
Download coupon a accolate accupril aciphex actonel actos advair alesse altace atrovent avandia avapro azopt b baclofen benoxyl betagan betaxolol bumex buspar c cafergot captopril cardizem cardura celebrex celexa cellcept cialis cimetidine cipro claritin cotazym cozaar d daypro depen detrol diovan doxepin e edecrin effexor elavil eltroxin evista exelon f famotidine feldene femara fenofibrate flamvir flexeril flomax flonase florinef floxin fosamax g gabapentin glyburide gonalf h halog herplex humatin hydralazine hydrea hytrin hyzaar i imdur imipramine imitrex isoptin j k keppra ketorolac l labetalol lanoxin lamictal lamisil lescol levsin levitra lipitor lopid lotensin m macrobid maxalt metformin metoprolol n naproxen nexium norvasc o p paroxetine plaquenil plavix prevastatin premarin prevacid propranolol protonix q r relafen reminyl s septra singulair synthroid t topamax u ultravate v vasotec viagra w wellbutrin x xenical y yohimbine z zestril zetia zocor zoloft generic name: famciclovir oral ; fam sye kloe veer ; brand names: famvir important information: famvir treatment should be started as soon as possible after the first appearance of symptoms e, g. I have been taking forever living product's aloe vera gel & more recently, forever freedom aloe gel for about 3 months as i was told it might improve the arthritis i had developed in my right knee. Veolia Environnement Kansai Elect ric Power Nat ional Grid Chubu Elect ric Power Tokyo Elect ric Power Gaz de France RWE lect ricit de France American Elect ric Power Exelon Vat t enf all Tohoku Elect ric Power SUEZ E.ON Cent rica Dominion Resources Endesa Const ellat ion Energy Duke Energy AREVA Enel OAO Gazprom Korea Elect ric Power Williams CFE Plains All American Pipeline RAO UES of Russia Gasunie China Sout hern Power Grid St at e Grid. Matutech, Inc. has performed an Independent review of the medical records of the abovenamed case to determine medical necessity. In performing this review, Matutech reviewed relevant medical records, any documents provided by the parties referenced above, and any documentation and written information submitted in support of the dispute. Matutech certifies that the reviewing healthcare professional in this case has certified to our organization that there are no known conflicts of interest that exist between him the provider, the injured employee, the injured employee's employer, the injured employee's insurance carrier, the utilization review agent, or any of the treating doctors or insurance carrier health care providers who reviewed the case for decision before referral to the Independent Review Organization. Information and medical records pertinent to this medical dispute were obtained from Luther Bratcher, D.C., and Randall Rogers, D.O. The Independent review was performed by a matched peer with the treating health care provider. This case was reviewed by the physician who is licensed in chiropractics and is currently on the DWC Approved Doctors List. Sincerely.

Exelon information